How Reliable Is The Pharma Equipment You Buy?
When it comes to equipment manufacturing in the pharmaceutical industry, it is imperative that a product functions exactly as it was intended. Any misstep caused by faulty equipment could have catastrophic results for the company that produces a drug, but more importantly, for the patient who uses it. The serious consequences that can result from a lack of accurate equipment design and the associated manufacturing processes are why Donald Dobert, president and COO of ATL Pharmaceutical/Medical, created his company’s New Product Development (NPD) Planning Process.
WHITE PAPERS & CASE STUDIES
Process For Scale-Up Of Adherent Vero Cells From Static Cell Factories To Influenza Production
In cell culture-based vaccine production, scale-up of adherent cells is challenging. This study shows a process for scaling up adherent Vero cells from static cell factories to influenza production at 50 L scale using WAVE Bioreactor™ systems and ReadyToProcess single-use equipment.
A Comparison Of Performance Using Three Bioreactor Systems
Eppendorf has introduced a new benchtop cell culture bioreactor that combines the benefits of single-use technology with the trusted performance and true scalability of a stirred-tank design. CelliGen™ BLU eliminates the need for autoclaving and cleaning, reduces validation requirements, provides rapid turn-around between runs, minimizes startup costs, and significantly reduces the risk of contamination because the culture vessel is only used once and then discarded.
Maintain The Benefits Of Single-Use Technology With Cell Culture Processing
Historically, stirred-tank bioreactors have been the standard for culturing all types of submerged cultures including suspension and anchorage-dependent mammalian, insect, yeast, plant and microbial cultures. By Nick Kohlstrom, Joseph Capone, and Ma Sha, Eppendorf Inc.